Kalogon, a Florida-based company developing smart seating solutions, has announced a $5.75 million funding round aimed at supporting its next stage of growth. The investment marks another step forward for the company as it expands its technology designed to improve comfort and health for people who spend extended periods sitting.
Founded in Melbourne, Florida, Kalogon has built a reputation for creating innovative seating products that use intelligent pressure-management technology. The company focuses on reducing the physical challenges associated with prolonged sitting, particularly for wheelchair users and others who rely on specialized seating systems.
A Focus on Seated Health
Kalogon’s products are powered by its proprietary Advanced Pressure Management (APM) technology. The system combines sensors, software, air bladders, and foam materials to monitor and adjust pressure in real time. The goal is to improve comfort, promote healthy blood flow, and reduce the risk of pressure-related injuries.
The company serves customers across healthcare, mobility, aviation, and defense sectors. Its technology has attracted attention for addressing long-standing challenges faced by people who remain seated for long periods.
Building on Recent Momentum
The funding announcement comes after a period of steady growth for Kalogon. Over the past few years, the company has expanded its product lineup and strengthened its presence in the mobility and healthcare markets.
Among its best-known products is the Orbiter Med smart wheelchair cushion, which received Medicare approval and broadened access to the company’s technology. Kalogon also introduced Bondar, a custom-fabricated wheelchair back support designed to provide additional postural support and comfort.
The company has also collaborated with organizations in the healthcare and government sectors while continuing research into pressure management and seated wellness.
Leadership Driving Innovation
Kalogon was co-founded by Tim Balz, who serves as the company’s Chief Executive Officer. Under his leadership, the company has focused on combining engineering, clinical research, and user-centered design to create practical solutions for everyday seating challenges.
The company believes that intelligent seating can play a significant role in improving quality of life, reducing discomfort, and supporting better long-term health outcomes for users.
Looking Ahead
With the newly announced funding, Kalogon is expected to continue expanding its technology platform and product offerings. The company remains focused on its mission of improving seated health through smart, adaptive seating solutions.
As demand grows for technology-driven healthcare and mobility products, Kalogon is positioning itself to play an increasingly important role in the future of smart seating. The latest investment highlights continued interest in solutions that combine medical innovation, engineering expertise, and real-world user needs.
